Avalo Therapeutics, Inc. (AVTX) › EPS (Diluted)Avalo Therapeutics, Inc. (AVTX) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2015: $-4.712016: $-1.872017: $0.422018: $-1.202022: $-1063.002023: $-113.582024: $-20.912025: $-5.84$-5.842015EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-5.84+72.1%2024$-20.91+81.6%2023$-113.58+89.3%2022$-1063.00—2018$-1.20-385.7%2017$0.42+122.5%2016$-1.87+60.3%2015$-4.71—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share